8-K - Prelude Therapeutics Incorporated | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other events On April 25, 2025, Prelude Therapeutics Incorporated (the "Company") issued a press release announcing the presentation of new preclinical data at

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release 104 Cover Page Interactive Data File (embedded within the Inline X

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1